Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals.
about
Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseasesCurcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin.Curcumin: A new candidate for melanoma therapy?Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: a possible therapy to alleviate autoimmune disorders.Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin.
P2860
Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Oral administration of heat-so ...... ility in experimental animals.
@en
Oral administration of heat-so ...... ility in experimental animals.
@nl
type
label
Oral administration of heat-so ...... ility in experimental animals.
@en
Oral administration of heat-so ...... ility in experimental animals.
@nl
prefLabel
Oral administration of heat-so ...... ility in experimental animals.
@en
Oral administration of heat-so ...... ility in experimental animals.
@nl
P2860
P356
P1476
Oral administration of heat-so ...... ility in experimental animals.
@en
P2093
Biji T Kurien
R Hal Scofield
P2860
P304
P356
10.1002/IJC.24547
P577
2009-10-01T00:00:00Z